What to watch with Longevity DNA Test and menopause?

The Longevity DNA Test from MyBody-X examines genetic variants related to aging, nutrient metabolism, and hormone pathways. During menopause, key genes include those involved in estrogen breakdown (e.g., CYP1A1, CYP1B1, COMT), bone health (e.g., VDR, COL1A1), and inflammation (e.g., IL-6, TNF-α). Results may indicate whether you have a slower clearance of estrogens or increased oxidative stress susceptibility. However, the evidence for actionable recommendations specifically in menopause is mostly mechanistic or extrapolated from non-menopausal populations (evidence: mixed/unclear). No established upper limits or toxicity thresholds are provided by the test for menopausal women. Caution: Do not start high-dose supplements (e.g., phytoestrogens, vitamin D, magnesium) solely based on genetic findings without medical supervision. The test can be a conversation starter with your gynecologist or endocrinologist, but it does not replace clinical monitoring of hormone levels, bone density, or cardiovascular risk. Always interpret results in the context of your full health picture.